About
Next-generation hemoperfusion devices to treat sepsis and multiple organ failure syndrome. Company's flagship product, Efferon LPS single-use hemoperfusion device is granted CE mark approval under EU MDR. Clinically validated approach, over 10.000 treated critical patients. Founded in 2016 to translate the most advanced polymeric adsorbent technology into routine clinical practice and to fight morbid diseases.
Technologies
WordPress.orgApacheMobile FriendlyYandex MetricaGoogle Tag Manager
Keywords
medical equipment manufacturingmedical deviceshospital & health care
Company Information
- Employees7
- Founded2016
Location
Hans-Gasser-Platz, Villach, Carinthia, Austria, 9500